Lead Monitor

Overview

Job Description Summary

Location:

London, Dublin, Barcelona

Role Type:
Hybrid Working, #LI-Hybrid

The Lead Central Monitor (Lead CM) supports the Central Monitoring Head to drive excellence in clinical trial monitoring by establishing and delivering a state-of-the-art Central Monitoring capability at Novartis in Global Clinical Operations (GCO). The Lead CM is responsible for managing a team of CMs, for developing central and site monitoring strategies, ensuring that the configuration of the CM platform aligns with strategic needs, is consistent with identified indications, program, and study risks, in alignment with the IQRMP, to ensure appropriate trial data surveillance in order to deliver quality and integrity of the trials’ clinical data.

The Lead CM will be responsible for a portfolio of programs and related trials within a Development Unit (DU). The role will be responsible for building DU knowledge in the CM team to set adapted strategies for CM. The Lead CM will sit at the GCO sub-team of the respective programs.

The Lead CM may also have trial’s role:

During trial start-up, this role will be involved for the protocol development process to support risk identification, risk assessment, risk oversight (ex: Key Risks Indicators - KRIs -) in partnership with the Risk Surveillance Lead (RSL). This role may also contribute to the establishment of trial-specific KRIs, as needed. During trial execution, the Lead CM will also be responsible for overseeing the CMs’ ongoing risk review, checking of the study data, and detection of risks utilizing technology (the CM platform) to monitor data quality, patient safety, and relevant risks.

The Lead CM will oversee the process whereby data are translated into signals and insights and communicated to the Clinical Trial Teams (CTTs) for review and decision making to investigate and act appropriately. This role is critical for the oversight of CM’s detection of study-related risk/issue(s) within the scope of study RBM strategy.

Job Responsibilities:

• CM Establishment:
  Support the establishment and implementation of a CM function at Novartis, including processes, tools, and governance frameworks to support RBQM.
• Contribute to the CM resourcing strategy, including hiring, onboarding, development, and retention of CM Team.
• Contribute to the Establishment and actively monitoring of CM objectives.
• Team Leadership and Oversight:
  Manage and mentor a team of CMs, fostering professional development, ensuring alignment with CM processes, and maintaining high performance across the team.
• Serve as the primary escalation point for CMs, providing guidance on complex risk signals and ensuring timely resolution of critical study-related risks.
• Strategic Input and Coordination:
  Partner with the CM Head to set, refine and implement the CM strategy, contributing to the continuous improvement of Risk-Based Monitoring (RBM) processes across the organization.
• Lead efforts to harmonize CM practices across studies, ensuring consistency in risk detection, assessment, and escalation protocols.
• Set, refine and implement CM strategy tailored to the associated risks within the assigned DU.
• Risk Management and Analytics Leadership:
  Oversee the analysis and interpretation of CM dashboards and data visualization tools to identify and contextualize risk signals and ensure accurate root cause analysis and mitigation actions
• Collaborate with cross-functional study teams, including RSL, Study Leaders, Data Managers, and Clinical Scientific Leaders, to ensure robust risk mitigation plans and issue resolutions are in place and effectively executed.
• Protocol and Study Design Support:
  Provide strategic input during protocol development and study setup to ensure comprehensive risk identification and alignment with RBQM objectives and processes.
• Advise on the design and optimization of KRIs and thresholds to enhance the efficacy of CM efforts.
• Data integrity and quality through
  
  Collaboration:
  
  Ensure appropriate trial data surveillance to deliver quality and integrity of the trials’ clinical data
• Act as the primary liaison between the CM team and CTTs and to RSL for Critical to Quality…